NASDAQ · APYX
Apyx Medical Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for APYX: Nov 05, 2026
Apyx Medical Corporation Common Stock is expected to report earnings on 11/05/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.07. The reported EPS for the same quarter last year was $-0.05.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Dec 2026 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Mar 2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Jun 2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · The Motley Fool · MarketBeat · Zacks- Fintel · Sep 29, 7:47 PM EDTMaxim Group Initiates Coverage of Apyx Medical with BuyFintel reports that on September 29, 2026, Maxim Group initiated coverage of Apyx Medical (NASDAQGS:APYX) (DB:BOV) with a Buy recommendation.Apyx Medical Corporation, based in the United States, operates primarily in the medical technology industry. The company focuses on advanci
- The Motley Fool · Aug 13, 8:13 PM EDTApyx Medical (APYX) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 11, 8:04 PM EDTApyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body ContouringApyx Medical (NASDAQ:APYX) is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwin said has been reshaped by the increasing use of GLP-1 weight-loss drugs. Spea
- Zacks · Aug 6, 7:10 PM EDTApyx Medical (APYX) Reports Q2 Loss, Beats Revenue EstimatesApyx (APYX) delivered earnings and revenue surprises of -16.67% and +10.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- MarketBeat · Aug 6, 6:04 PM EDTApyx Medical Q2 Earnings Call HighlightsApyx Medical (NASDAQ:APYX) reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international generator sales and domestic demand for single-use handpieces. Total revenue for the
- RTTNews · May 21, 11:04 AM EDTApyx Releases Positive Clinical Data For Renuvion In Cellulite Reduction(RTTNews) – Apyx Medical Corporation (APYX), a surgical technology company, on Thursday published new clinical data for the surgical technique Renuvion in reducing cellulite and skin laxity in the Aesthetic Surgery Journal Open Forum.
- RTTNews · May 15, 8:08 AM EDTWeekly Buzz: Lilly Posts Positive Trial Data, Rigel Licenses PROTAC Drug, BMY Strikes $15.2B Deal(RTTNews) – This week's biotech highlights Lilly's strong Phase 3b maintenance results for Zepbound and Foundaya, Rigel's global license for the first FDA-approved PROTAC therapy Veppanu, and Bristol Myers Squibb's $15.2 billion collaboration with Hengrui Pharma. The regulatory f
- RTTNews · May 11, 9:42 AM EDTApyx Medical Expands FDA Clearance For AYON Body Conturing System(RTTNews) – Apyx Medical Corporation (APYX) announced that the U.S. FDA has granted expanded 510(k) clearance for its AYON Body Contouring System to include power liposuction capability.
- The Motley Fool · May 8, 11:16 AM EDTApyx Medical (APYX) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · May 7, 9:22 AM EDTApyx Medical Q1 Earnings Call HighlightsApyx Medical (NASDAQ:APYX) reported first quarter 2026 revenue of $12.5 million, up from $9.4 million in the prior-year period, driven primarily by growth in its Surgical Aesthetics business and continued momentum from the company’s AYON body contouring system, which launched com
- Zacks · May 6, 7:45 AM EDTPerrigo (PRGO) Q1 Earnings Beat EstimatesPerrigo (PRGO) delivered earnings and revenue surprises of +10.26% and -4.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Apr 20, 9:40 AM EDTIs Agenus (AGEN) Outperforming Other Medical Stocks This Year?Here is how Agenus (AGEN) and Apyx Medical (APYX) have performed compared to their sector so far this year.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Apyx Medical Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.